Launched in 2021, the company aims to reduce the unnecessary communications between clinicians and patients by providing contextualized lab results and action items. Tusk Venture Partners led the financing round, according to a Jan. 26 Elaborate news release.
The tool is designed to help clinicians comply with the medical record-sharing stipulations of the 21st Century Cures Act.
“What the team at Elaborate has been able to do for their clients, including my practice, is nothing short of remarkable,” Amy Esposito, MD, Elaborate medical advisory board member and medical director of New York City-based Reside Health, said in the release. “Because they’re plugged into the EHR, they use all of the information in the patient’s chart to summarize the key findings and help them schedule a billable follow-up visit if necessary. Plus they customize everything in our clinical protocols for us.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
